Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial

M Uhari, T Kontiokari, M Koskela, M Niemelä, M Uhari, T Kontiokari, M Koskela, M Niemelä

Abstract

Objective: To examine whether xylitol, which reduces the growth of Streptococcus pneumoniae, might have clinical importance in the prevention of acute otitis media.

Design: A double blind randomised trial with xylitol administered in chewing gum.

Setting: Eleven day care nurseries in the city of Oulu. Most of the children had had problems with recurrent acute otitis media.

Subjects: 306 day care children: 149 children in the sucrose group (76 boys; mean (SD) age 4.9 (1.5) years) and 157 in the xylitol group (80 boys; 5.0 (1.4) years).

Intervention: Either xylitol (8.4 g a day) or sucrose (control) chewing gum for two months.

Main outcome measures: The occurrence of acute otitis media and antimicrobial treatment received during the intervention and nasopharyngeal carriage of S pneumoniae.

Results: During the two month monitoring period at least one event of acute otitis media was experienced by 31/149 (20.8%) children who received sucrose compared with 19/157 (12.1%) of those receiving chewing gum containing xylitol (difference 8.7%; 95% confidence interval 0.4% to 17.0%; P = 0.04). Significantly fewer antimicrobials were prescribed among those receiving xylitol: 29/157 (18.5%) children had at least one period of treatment versus 43/149 (28.9%) (difference 10.4%; 0.9% to 19.9%; P = 0.032). The carriage rate of S pneumoniae varied from 17.4% to 28.2% with no difference between the groups. Two children in the xylitol group experienced diarrhoea, but no other adverse effects were noted among the xylitol users.

Conclusion: Xylitol seems to have a preventive effect against acute otitis media.

References

    1. Int J Pediatr Otorhinolaryngol. 1991 Feb;21(1):7-14
    1. Ann Otol Rhinol Laryngol Suppl. 1987 Mar-Apr;129:1-19
    1. Acta Otolaryngol. 1987 Jul-Aug;104(1-2):138-45
    1. Caries Res. 1988;22(1):55-62
    1. Int J Pediatr Otorhinolaryngol. 1989 Feb;17(1):37-49
    1. Scand J Infect Dis. 1981;13(3):177-83
    1. Pediatr Infect Dis J. 1993 Jan;12(1):62-9
    1. Antimicrob Agents Chemother. 1995 Aug;39(8):1820-3
    1. J Dent Res. 1995 Dec;74(12):1904-13
    1. Caries Res. 1975;9(3):177-89
    1. Acta Odontol Scand. 1975;33(1):1-4

Source: PubMed

3
購読する